Paul J. Gaglio, MD, FACP

Academic Appointments

  • Professor of Medicine (in Surgery) at CUMC

Current Administrative Positions

  • Director, Hepatology Outreach
Paul J. Gaglio, MD, FACP

Paul J. Gaglio, MD FACP, AGAF, FAASLD, Professor of Medicine (in Surgery) is the newly appointed director of Hepatology Outreach at NY-Presbyterian Hospital, Columbia University Irving Medical Center. He is the former medical director of Adult Liver Transplantation at The Montefiore Medical Center, Columbia Presbyterian Hospital, and The Tulane University Medical Center. Dr. Gaglio received his bachelor’s in Biology/Physiology from Rutgers College in New Brunswick, NJ, and his M.D. from UMDNJ-New Jersey Medical School. He completed an internship and residency at Mount Sinai Medical Center in New York City, and a digestive disease/liver transplantation fellowship at New Jersey Medical School. Dr. Gaglio has published multiple manuscripts, book chapters, and abstracts, and has participated in numerous research trials related to the therapy of hepatitis B and C, liver transplantation, and treatment of liver failure. Dr. Gaglio has lectured nationally and internationally on these topics. He is a Fellow of the American College of Physicians, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases. His research interests include treatment of hepatitis B and C, the natural history of hepatitis C in liver transplant recipients, and non-alcoholic fatty liver disease.He is consistently listed in Castle Connolly Top Doctors; NY Metro Area, Marquis Who’s Who in America, and has received several teaching awards. In 2011, he was named Physician of the Year, NY Chapter of the American Liver Foundation.

Education and Training

  • UMDNJ - New Jersey School of Medicine
  • Internship: Mount Sinai Hospital
  • Residency: Mount Sinai Hospital
  • Fellowship: UMDNJ New Jersey Medical School

Past Positions

  • Columbia University College of Physicians and Surgeons, Professor of Medicine, Center for Liver Disease and Transplantation, 2015-Present
  • NY-Presbyterian Hospital/Columbia University Medical Center, Director of Hepatology Outreach, 2015-Present
  • Albert Einstein College of Medicine, Montefiore-Einstein Liver Center, Professor of Clinical Medicine, Medical Director: Adult Liver Transplantation-Montefiore Medical Ctr., Primary Liver Transplantation Physician - Montefiore Medical Ctr., 2007-Present
  • Columbia University Collegeo of Physicians and Surgeons, Associate Clinical Professor of Medicine (in Surgery), Associate Medical Director: Center for Liver Disease and Transplantation, Medical Director: Adult Liver Transplantation, 2001-2007
  • Tulane University Medical School, Associate Professor of Clinical Medicine and Digestive Diseases: Director-Academic Hepatology, Medical Co-Director, Liver Transplantation, Faculty: Molecular and Cellural Biology Program, 1996-2001
  • UMDNJ-New Jersey Medical School, Assistant Professor of Medicine and Digestive Diseases, 1993-1996

Committees / Societies / Memberships

  • American Association for the Study of Liver Disease
  • European Association for the Study of the Liver
  • American Society of Transplantation
  • American Liver Foundation
  • American Gastroenterology Association
  • International Liver Transplantation Society
  • International Hepatitis Society
  • United Network for Organ and Tissue Sharing; Liver Transplantation
  • American Foundation for Medical Research
  • Columbia University Department of Medicine Executive Committee
  • Columbia University Liver Transplantation Selection Committee
  • American College of Physicians
  • New York Consortium for Liver Transplantation
  • Empire Liver Foundation Medical Advisory Board
  • Hep C Link to Care Initiative NYC Medical Advisory Board

Honors and Awards

Phi Beta Kappa 1984

Henry Rutgers Honor Society 1984

Alpha Omega Alpha 1988

Sigma XI 1988

Chief Digestive Disease Fellow UMDNJ NJ Medical School 1992-1993

Surgical Houstaff Teaching Award Tulane University 2001

Fellow American College of Physicians 2001

Fellow American Gastroenterological Association 2008

Fellow American Association for the Study of Liver Disease 2014

“Best Doctors® in America” 2009-2020

Castle Connolly Top Doctors; New York Metro Area 2012-2020

Physician of the Year, New York Chapter, American Liver Foundation 2011

Marquis Who's Who In America 2013-2020


  1. Thompson J, Jones N, Al-Khafaji A, Gaglio P, et al VTI-208 Study Group.Extracorporeal Cellular Therapy (ELAD) in Severe Alcoholic Hepatitis - A Multinational, Prospective, Controlled, Randomized Trial. Liver Transplantation 2018;24:380-393
  2. Lubetzky, M, Soowan C, Joelson A, Coco M, Kamal L, Ajaimy M, Gaglio PJ, Akalin E and Deboccardo G Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents Transplantation. 2017;101(7):1704-1710
  3. Izzy M, Jibara G, Aljanabi A, Alani M, Giannattasio E, Zaidi H, Said Z, Gaglio P, Wolkoff A, Reinus JF. Limited Fibrosis Progression but Significant Mortality in Patients Ineligible for Interferon-Based Hepatitis C Therapy. J Clin Exp Hepatol. 2016;6(2):100-8
  4. Zahiruddin A, Farahmand A, Gaglio P, Massoumi H.Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population. Gastroenterol Hepatol Bed Bench. 2016;9(3):225-30.
  5. Jermyn R, Soe E, D'Alessandro D, S
  6. hin J, Jakobleff W, Schwartz D, Kinkhabwala M, Gaglio PJ. Cardiac failure after liver transplantation requiring a biventricular assist device. Case Rep Transplant. 2014;2014:946961
  7. Tandan S, Sun K, Gaglio PJ A Rare Finding on Liver Explant. Clin Gastroenterol Hepatol. 2014 Sep;12(9):e85
  8. Bichoupan K, Schwartz JM, Martert V, Giannattasio ER, Marfo K, Odin J, Liu L, Schiano T, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich D, Branch A, Reinus JP. Effect of Fibrosis on Adverse Events in Hepatitis C Patients treated with Telaprevir Aliment Pharmacol Ther. 2014;39:209-216.
  9. Kinkhabwala M, Lindower J, Principe AL, Reinus J, Gaglio PJ. Expedited Liver Allocation in the US: A Critical Analysis. Liver Transplantation 2013;19(10):1159-65
    Gaglio PJ, Marfo K, Chiodo J. Hyponatremia in Cirrhosis and End Stage Liver Disease; Treatment with the Vasopressin V2 Receptor Antagonist Tolvaptan: Dig Dis Sci. 2012 Nov;57(11):2774-8
  10. Flattau, A, Gaglio PJ, et al. Social Bariers to Adult Liver Transplantation Listing; Prevalence and Association with Program Characteristics: Liver Transpl. 2011;17:1167-1175
  11. Degertekin B, Han SH, Keeffe EB, Gaglio PJ. Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.; NIH HBV-OLT Study Group. Am J Transplant. 2011;10:1823-33
  12. Gaglio PJ, Moss N, McGaw C, Reinus J Direct Acting Antiviral Therapy for Hepatitis C; Attitudes Regarding Future Use: Dig Dis Sci. 2011;56:1509-15.

For a complete list of publications, please visit